Archive

HIGHLIGHTS

 
LSP’s portfolio company Neuravi acquired by Codman Neuro
Amsterdam, the Netherlands, April 10, 2017 – LSP (Life Sciences Partners), a leading European investor in health care, announces the acquisition of its portfolio company Neuravi Limited by Codman Neuro, part of the [...]
 
LSP COMPANY NEWS
LSP's portfolio company Atlas Genetics raises $ 35M
 
LSP FUNDRAISING NEWS
LSP and Bristol-Myers Squibb enter into strategic collaboration for life sciences innovation in Europe
 
Marco Groot over LSP in het FD
Lees de gehele column: Een absoluut beter resultaat
 
LSP COMPANY NEWS
Impacting patient lives with new diabetes drug
 
LSP COMPANY NEWS
Kiadis will start trial to treat children with severe blood disorder
 
LSP COMPANY NEWS
LSP Venture Partner Hans Clevers gets prestigious Körber Award for his ground breaking research into stem cells and organoids, and appears in German prime time television news
 
15th BioCapital Europe
March 15, 2017 – The 15th BioCapital Europe Conference took place at the prestigious The Grand Hotel (Sofitel) in Amsterdam. The conference is organized by LSP and this year attracted a record breaking attendance. D[...]
 
LSP FUNDRAISING NEWS
LSP announces $280 million final closing of life sciences venture fund
 
LSP RECOMMENDS
Wireless brain-spine connection to overcome paralysis
 
LSP COMPANY NEWS
LSP’s portfolio company Merus announces deal with Incyte

2017


Kiadis Pharma announces filing of marketing authorization with the European Medicines Agency for ATIR101™ in blood cancers
Amsterdam, The Netherlands, April 26, 2017 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative pro [...]
Recent Data on Curetis’ Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits
Several ECCMID 2017 presentations highlight advantages of rapid time to result with Unyvero ITI in Prosthetic Joint Infections   Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 27, 2017 - C [...]
argenx announces results of Annual General Meeting 2017
Breda, the Netherlands / Ghent, Belgium, April 26, 2017 - argenx N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for [...]
argenx files registration statement for a proposed public offering in the United States
Breda, the Netherlands / Ghent, Belgium, April 24, 2017 - argenx N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for [...]
Merus Announces Data from a Phase 1/2 Study of MCLA-128 to be Presented at the 2017 American Society of Clinical Oncology Annual Meeting
UTRECHT, The Netherlands, April 20, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that data from a [...]
argenx receives first preclinical milestone payment in AbbVie collaboration
Breda, the Netherlands/Ghent, Belgium - April 13, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatmen [...]


2017
2016
2015
2014
2013
2012
back to news overview

Archive

HIGHLIGHTS

 
LSP’s portfolio company Neuravi acquired by Codman Neuro
Amsterdam, the Netherlands, April 10, 2017 – LSP (Life Sciences Partners), a leading European investor in health care, announces the acquisition of its portfolio company Neuravi Limited by Codman Neuro, part of the [...]
 
LSP COMPANY NEWS
LSP's portfolio company Atlas Genetics raises $ 35M
 
LSP FUNDRAISING NEWS
LSP and Bristol-Myers Squibb enter into strategic collaboration for life sciences innovation in Europe
 
Marco Groot over LSP in het FD
Lees de gehele column: Een absoluut beter resultaat
 
LSP COMPANY NEWS
Impacting patient lives with new diabetes drug
 
LSP COMPANY NEWS
Kiadis will start trial to treat children with severe blood disorder
 
LSP COMPANY NEWS
LSP Venture Partner Hans Clevers gets prestigious Körber Award for his ground breaking research into stem cells and organoids, and appears in German prime time television news
 
15th BioCapital Europe
March 15, 2017 – The 15th BioCapital Europe Conference took place at the prestigious The Grand Hotel (Sofitel) in Amsterdam. The conference is organized by LSP and this year attracted a record breaking attendance. D[...]
 
LSP FUNDRAISING NEWS
LSP announces $280 million final closing of life sciences venture fund
 
LSP RECOMMENDS
Wireless brain-spine connection to overcome paralysis
 
LSP COMPANY NEWS
LSP’s portfolio company Merus announces deal with Incyte

$smarty.now|date_format:"%Y"


Kiadis Pharma announces filing of marketing authorization with the European Medicines Agency for ATIR101™ in blood cancers
Amsterdam, The Netherlands, April 26, 2017 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative pro [...]
Recent Data on Curetis’ Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits
Several ECCMID 2017 presentations highlight advantages of rapid time to result with Unyvero ITI in Prosthetic Joint Infections   Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 27, 2017 - C [...]
argenx announces results of Annual General Meeting 2017
Breda, the Netherlands / Ghent, Belgium, April 26, 2017 - argenx N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for [...]
argenx files registration statement for a proposed public offering in the United States
Breda, the Netherlands / Ghent, Belgium, April 24, 2017 - argenx N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for [...]
Merus Announces Data from a Phase 1/2 Study of MCLA-128 to be Presented at the 2017 American Society of Clinical Oncology Annual Meeting
UTRECHT, The Netherlands, April 20, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that data from a [...]
argenx receives first preclinical milestone payment in AbbVie collaboration
Breda, the Netherlands/Ghent, Belgium - April 13, 2017 - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatmen [...]


2017
2016
2015
2014
2013
2012
back to news overview